Overview

A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Ceftriaxone
Clavulanic Acid
Clavulanic Acids
Lactams